Smoking CessationNCT07075068
The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination
An observational study of Smoking Cessation, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
This observational study will aim to investigate the effects of cigarette addiction on lower extremity motor coordination and movement speed in young adults. The study will include healthy participants aged 18-25 years, divided into smokers and non-smokers. Read more about this study
- Who is it for?
- Ages 18 to 25 years
- Conditions the study is for
- Smoking Cessation
- What is being tested?
- Behavioral and Functional Performance Assessment Battery
- Type of treatment
- Injection or infusion
- How many people
- 24 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 29 Jul 2025to 20 Jul 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- Adult
Study population: The study population will consist of healthy young adults aged between 18 and 25 years. A total of 24 participants will be included, with 12 individuals who meet the criteria for cigarette dependence and 12 who do not smoke. Participants will be recruited from a university setting using convenience and snowball sampling methods. All participants will be required to be cooperative, literate, and able to walk independently. They will also be screened to ensure a body mass index (BMI) between 18.5 and 29.9 kg/m². Smokers will be identified based on the World Health Organization (WHO) definition and the DSM-IV-TR diagnostic criteria. Individuals with orthopedic, neurologic, cardiopulmonary, or cognitive impairments will be excluded.
Who may be able to join
- Age between 18 and 25 years
- Able to walk independently
- Literate and cooperative
- Willing to participate voluntarily
- BMI between 18.5 and 29.9 kg/m²
- Additional inclusion for smokers:
- Daily smoking for at least one year based on WHO and DSM-IV-TR definitions
Who cannot join
- Orthopedic, neurologic, or neuromuscular disorders affecting gait
- Chronic cardiopulmonary disease
- Cognitive impairments
- Obesity (BMI ≥ 30 kg/m²)
- Additional exclusion for smokers:
- History of acute cardiovascular events
- Chronic heart failure or lung diseases
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Edanur Kocakaplan contact
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Esra Pehlivan
Istanbul, Üsküdar, 34668
ESRA PEHLİVAN, 02164189616, fztesrakambur@yahoo.com
About this study
Official title: The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination in Young Adults
This observational study will aim to investigate the effects of cigarette addiction on lower extremity motor coordination and movement speed in young adults. The study will include healthy participants aged 18-25 years, divided into smokers and non-smokers. Motor coordination will be assessed using the Lower Extremity Motor Coordination Test (LEMOCOT), and speed will be evaluated with a 30-meter sprint test. Nicotine dependence will be evaluated in smokers using the Fagerström Test. The findings will provide insight into the possible functional impacts of nicotine addiction on motor performance.
Read the detailed description
The study will be conducted as a non-randomized controlled observational trial at the Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation. A total of 24 healthy young adults (12 smokers, 12 non-smokers) will participate. The inclusion criteria will require participants to be aged 18-25, cooperative, literate, and able to walk independently. Participants will be categorized as smokers based on WHO and DSM-IV-TR criteria. The primary assessments will include LEMOCOT and 30-meter sprint test. Nicotine addiction will be measured using the Fagerström Test for Nicotine Dependence (FTND), and anthropometric data including BMI and bimalleolar diameter will also be recorded. Data will be analyzed to determine any statistical differences or correlations between smoking status and motor performance outcomes.
- Conditions
- Smoking Cessation
- Being tested
- Behavioral and Functional Performance Assessment Battery
- Medical subject headings
- Smoking Cessation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Behavioral and Functional Performance Assessment BatteryDiagnostic test
This study will include only observational functional assessments. No active intervention will be performed.This observational protocol will involve standardized assessments of lower extremity coordination (LEMOCOT), movement speed (30-meter sprint), and smoking-related behavioral patterns (Fagerström Test for Nicotine Dependence). These tools will be used to evaluate the potential impact of cigarette addiction on physical performance in young adults. No therapeutic or pharmacological intervention will be applied.
| Study group | Role | What they receive |
|---|---|---|
| Smokers | Individuals who will meet WHO and DSM-IV-TR criteria for cigarette dependence. Receives: Diagnostic Test: Behavioral and Functional Performance Assessment Battery | |
| Non-Smokers | Individuals who will report no smoking behavior in the past year. Receives: Diagnostic Test: Behavioral and Functional Performance Assessment Battery |
What is being measured
The primary outcome is the main question the study is designed to answer.
LEMOCOT Score (Lower Extremity Motor Coordination Test)
The number of correct taps within 20 seconds will be measured for each participant.
Measured: Baseline
30-Meter Sprint Time
Time (in seconds) required to complete a 30-meter sprint will be recorded and averaged from two trials.
Measured: Baseline
Secondary outcomes (3)
Fagerström Test for Nicotine Dependence Score
Degree of nicotine dependence will be evaluated in smokers using the Fagerström Test for Nicotine Dependence.
Measured: Baseline
Body Mass Index (BMI)
BMI will be calculated using height and weight measurements (BMI = weight (kg) / height² (m²)).
Measured: Baseline
Bimalleolar Circumference and Diameter Measurement
The circumference at the level of the medial and lateral malleoli will be measured using a flexible tape measure while the participant is in a supine position.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2025
- Study start29 Jul 2025
- Primary completion20 Jul 2026 (estimated)
- Study completion20 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Smoking CessationStudies of the same condition, open and under way.
- More trials run by Saglik Bilimleri UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 24 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, ESRA PEHLIVAN, Saglik Bilimleri Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07075068
- Sponsor's protocol ID
- Smoking&Speed
- Status last verified
- Jul 2025
- First submitted
- 10 Jul 2025
- Last updated
- 30 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination in Young Adults
- ClinicalTrials.gov ID
- NCT07075068
- Acronym / sponsor ID
- Smoking&Speed
- Conditions
- Smoking Cessation
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 24 participants (estimated)
- Lead sponsor
- Saglik Bilimleri UniversitesiUniversity, hospital or other
- Study start
- 29 Jul 2025 (actual)
- Primary completion
- 20 Jul 2026 (estimated)
- Study completion
- 20 Jul 2026 (estimated)
- First posted
- 20 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This observational study will aim to investigate the effects of cigarette addiction on lower extremity motor coordination and movement speed in young adults. The study will include healthy participants aged 18-25 years, divided into smokers and non-smokers. Motor coordination will be assessed using the Lower Extremity Motor Coordination Test (LEMOCOT), and speed will be evaluated with a 30-meter sprint test. Nicotine dependence will be evaluated in smokers using the Fagerström Test. The findings will provide insight into the possible functional impacts of nicotine addiction on motor performance.
Detailed description
The study will be conducted as a non-randomized controlled observational trial at the Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation. A total of 24 healthy young adults (12 smokers, 12 non-smokers) will participate. The inclusion criteria will require participants to be aged 18-25, cooperative, literate, and able to walk independently. Participants will be categorized as smokers based on WHO and DSM-IV-TR criteria. The primary assessments will include LEMOCOT and 30-meter sprint test. Nicotine addiction will be measured using the Fagerström Test for Nicotine Dependence (FTND), and anthropometric data including BMI and bimalleolar diameter will also be recorded. Data will be analyzed to determine any statistical differences or correlations between smoking status and motor performance outcomes.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Smokers | – | Diagnostic Test: Behavioral and Functional Performance Assessment BatteryIndividuals who will meet WHO and DSM-IV-TR criteria for cigarette dependence. |
| Non-Smokers | – | Diagnostic Test: Behavioral and Functional Performance Assessment BatteryIndividuals who will report no smoking behavior in the past year. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Age groups
- Adult
- Study population
- The study population will consist of healthy young adults aged between 18 and 25 years. A total of 24 participants will be included, with 12 individuals who meet the criteria for cigarette dependence and 12 who do not smoke. Participants will be recruited from a university setting using convenience and snowball sampling methods. All participants will be required to be cooperative, literate, and able to walk independently. They will also be screened to ensure a body mass index (BMI) between 18.5 and 29.9 kg/m². Smokers will be identified based on the World Health Organization (WHO) definition and the DSM-IV-TR diagnostic criteria. Individuals with orthopedic, neurologic, cardiopulmonary, or cognitive impairments will be excluded.
Key inclusion criteria (7 listed)
- Age between 18 and 25 years
- Able to walk independently
- Literate and cooperative
- Willing to participate voluntarily
- BMI between 18.5 and 29.9 kg/m²
Key exclusion criteria (7 listed)
- Orthopedic, neurologic, or neuromuscular disorders affecting gait
- Chronic cardiopulmonary disease
- Cognitive impairments
- Obesity (BMI ≥ 30 kg/m²)
- History of acute cardiovascular events
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Behavioral and Functional Performance Assessment BatteryThis study will include only observational functional assessments. No active intervention will be performed.This observational protocol will involve standardized assessments of lower extremity coordination (LEMOCOT), movement speed (30-meter sprint), and smoking-related behavioral patterns (Fagerström Test for Nicotine Dependence). These tools will be used to evaluate the potential impact of cigarette addiction on physical performance in young adults. No therapeutic or pharmacological intervention will be applied. | Diagnostic test | Non-Smokers, Smokers |
Primary outcome
LEMOCOT Score (Lower Extremity Motor Coordination Test)
Time frame: Baseline
The number of correct taps within 20 seconds will be measured for each participant.
30-Meter Sprint Time
Time frame: Baseline
Time (in seconds) required to complete a 30-meter sprint will be recorded and averaged from two trials.
3 secondary outcomes
Fagerström Test for Nicotine Dependence Score
Time frame: Baseline
Body Mass Index (BMI)
Time frame: Baseline
Bimalleolar Circumference and Diameter Measurement
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jul 2025.
Related trials for Smoking Cessation
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Not yet recruitingObservational study
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
Smoking Cessation, Lung Cancer Screening
Not yet recruiting
Impacto 2.0: Mobile Smoking Cessation Across Texas
Cigarette Smoking, Smoking Cessation
Not yet recruiting
Smoking Cessation Program for Lao People With HIV
Smoking Cessation, HIV
RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Smoking Cessation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Edanur Kocakaplan contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Smoking Cessation, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact ESRA PEHLİVAN (+90 777 87 77, fztesrakambur@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
LEMOCOT Score (Lower Extremity Motor Coordination Test) (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.